Purinergic receptors in adipose tissue as potential targets in metabolic disorders

Research output: Contribution to journal › Review › Research › peer-review

Standard

Purinergic receptors in adipose tissue as potential targets in metabolic disorders. / Tozzi, Marco; Novak, Ivana.

In: Frontiers in Pharmacology, Vol. 8, 878, 24.11.2017.

Research output: Contribution to journal › Review › Research › peer-review

Harvard

Tozzi, M & Novak, I 2017, 'Purinergic receptors in adipose tissue as potential targets in metabolic disorders', Frontiers in Pharmacology, vol. 8, 878. https://doi.org/10.3389/fphar.2017.00878

APA

Tozzi, M., & Novak, I. (2017). Purinergic receptors in adipose tissue as potential targets in metabolic disorders. Frontiers in Pharmacology, 8, [878]. https://doi.org/10.3389/fphar.2017.00878

Vancouver

Tozzi M, Novak I. Purinergic receptors in adipose tissue as potential targets in metabolic disorders. Frontiers in Pharmacology. 2017 Nov 24;8. 878. https://doi.org/10.3389/fphar.2017.00878

Author

Tozzi, Marco ; Novak, Ivana. / Purinergic receptors in adipose tissue as potential targets in metabolic disorders. In: Frontiers in Pharmacology. 2017 ; Vol. 8.

Bibtex

@article{cad3b511e14a4423b2559e3af7efc94e,
title = "Purinergic receptors in adipose tissue as potential targets in metabolic disorders",
keywords = "purinergic receptors, adenosine, ATP, adipocytes, obesity, type-2 diabetes, inflammation, adipose tissue",
author = "Marco Tozzi and Ivana Novak",
year = "2017",
month = nov,
day = "24",
doi = "10.3389/fphar.2017.00878",
language = "English",
volume = "8",
journal = "Frontiers in Pharmacology",
issn = "1663-9812",
publisher = "Frontiers Research Foundation",

}

RIS

TY - JOUR

T1 - Purinergic receptors in adipose tissue as potential targets in metabolic disorders

AU - Tozzi, Marco

AU - Novak, Ivana

PY - 2017/11/24

Y1 - 2017/11/24

KW - purinergic receptors

KW - adenosine

KW - ATP

KW - adipocytes

KW - obesity

KW - type-2 diabetes

KW - inflammation

KW - adipose tissue

U2 - 10.3389/fphar.2017.00878

DO - 10.3389/fphar.2017.00878

M3 - Review

C2 - 29249968

VL - 8

JO - Frontiers in Pharmacology

JF - Frontiers in Pharmacology

SN - 1663-9812

M1 - 878

ER -

ID: 187016376